CA2696499A1 - Use of extracts or of extract compounds from piper cubeba l. as active components in a medicament for the treatment of cancer - Google Patents

Use of extracts or of extract compounds from piper cubeba l. as active components in a medicament for the treatment of cancer Download PDF

Info

Publication number
CA2696499A1
CA2696499A1 CA2696499A CA2696499A CA2696499A1 CA 2696499 A1 CA2696499 A1 CA 2696499A1 CA 2696499 A CA2696499 A CA 2696499A CA 2696499 A CA2696499 A CA 2696499A CA 2696499 A1 CA2696499 A1 CA 2696499A1
Authority
CA
Canada
Prior art keywords
extract
alcohol
cancer
process according
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2696499A
Other languages
English (en)
French (fr)
Inventor
Matthias-Heinrich Kreuter
Jian Ying Yam
Karin Berger-Buter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viridis Pharmaceutical Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2696499A1 publication Critical patent/CA2696499A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2696499A 2007-08-16 2008-08-15 Use of extracts or of extract compounds from piper cubeba l. as active components in a medicament for the treatment of cancer Abandoned CA2696499A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1289/07 2007-08-16
CH01289/07A CH698627B1 (de) 2007-08-16 2007-08-16 Herstellung und Verwendung von Extrakten oder Extraktivstoffen aus Piper cubeba L. als wirksame Bestandteile in einem Medikament zur Behandlung von Krebserkrankungen.
PCT/CH2008/000350 WO2009021347A1 (de) 2007-08-16 2008-08-15 Verwendung von extrakten oder extraktivstoffen aus piper cubeba l. als wirksame bestandteile in einem medikament zur behandlung von krebserkrankungen

Publications (1)

Publication Number Publication Date
CA2696499A1 true CA2696499A1 (en) 2009-02-19

Family

ID=38668948

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2696499A Abandoned CA2696499A1 (en) 2007-08-16 2008-08-15 Use of extracts or of extract compounds from piper cubeba l. as active components in a medicament for the treatment of cancer

Country Status (14)

Country Link
US (3) US8404286B2 (enExample)
EP (1) EP2182966B1 (enExample)
JP (1) JP5378379B2 (enExample)
KR (1) KR20100089815A (enExample)
CN (1) CN102065875B (enExample)
AU (1) AU2008286636B2 (enExample)
BR (1) BRPI0815188A2 (enExample)
CA (1) CA2696499A1 (enExample)
CH (1) CH698627B1 (enExample)
ES (1) ES2392310T3 (enExample)
PL (1) PL2182966T3 (enExample)
RU (1) RU2470657C2 (enExample)
WO (1) WO2009021347A1 (enExample)
ZA (1) ZA201000959B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI472333B (zh) * 2008-06-26 2015-02-11 Piramal Entpr Ltd 治療口腔念珠菌病之口服草本組成物
JP5806231B2 (ja) * 2009-12-21 2015-11-10 アセフ エス．アー． 勃起障害の治療における血管拡張剤としてのクベビン、ジベンジルブチルロラクトリンリグナン、その半合成誘導体および合成誘導体、ならびに他のリグナンおよびネオリグナン
WO2014027857A1 (ko) * 2012-08-16 2014-02-20 부산대학교 산학협력단 알파-이소-쿠베벤 또는 알파-이소-쿠베베놀을 유효성분으로 포함하는 감염성 및 염증성 질환의 예방 또는 치료용 조성물
WO2014086379A1 (en) 2012-12-03 2014-06-12 Alpinia Laudanum Institute Of Phytopharmaceutical Sciences Ag Lignan compositions
FR3085846B1 (fr) * 2018-09-13 2022-01-21 Robertet Sa Utilisation d’extrait de p.nigrum, p. cubeba et/ou s. therebentifolius dans des preparations cosmetiques pour favoriser la pousse des poils
JP7197908B2 (ja) * 2019-03-04 2022-12-28 株式会社ナチュファルマ琉球 骨減少性疾患の予防及び／又は治療用組成物
CN114574286B (zh) * 2022-02-18 2024-03-22 中国热带农业科学院香料饮料研究所 一种具有抗炎活性的胡椒精油及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815177D0 (en) * 1998-07-13 1998-09-09 King S College London Treatment of skin disorders
JP3091962B2 (ja) * 1998-09-25 2000-09-25 アルプス薬品工業株式会社 テストステロン−５α−レダクターゼ阻害剤
WO2003047551A1 (en) * 2001-11-29 2003-06-12 Penwest Pharmaceutical Company Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
BR0201237A (pt) 2002-03-25 2003-12-02 Fundacao De Amparo A Pesquisa Processo de obtenção de lignanas dibenzilbutirolactÈnicas, processo de obtenção de derivados sintéticos de lignanas ostentando atividades quimioprofilática e terapêutica antichagásica
US20030228383A1 (en) * 2002-06-06 2003-12-11 J.B. Chemicals & Pharmaceuticals, Ltd. Herbal cough formulations and process for the preparation thereof
JP2004160165A (ja) * 2002-09-17 2004-06-10 Pauretsuku:Kk 生薬成分製剤の造粒方法
EP1581237B1 (en) * 2002-12-30 2007-06-27 Council of Scientific and Industrial Research Development of an anti-cough, anti-tussive and throat soothing herbal formulation
JP4319417B2 (ja) * 2003-01-30 2009-08-26 学校法人近畿大学 メラニン産生不全症治療剤
US20070248693A1 (en) * 2003-08-02 2007-10-25 Elizabeth Mazzio Nutraceutical composition and method of use for treatment / prevention of cancer

Also Published As

Publication number Publication date
KR20100089815A (ko) 2010-08-12
EP2182966B1 (de) 2012-08-08
AU2008286636A1 (en) 2009-02-19
RU2470657C2 (ru) 2012-12-27
WO2009021347A1 (de) 2009-02-19
AU2008286636B2 (en) 2013-10-24
US20110135760A1 (en) 2011-06-09
JP5378379B2 (ja) 2013-12-25
CH698627B1 (de) 2009-09-15
ZA201000959B (en) 2010-10-27
CN102065875B (zh) 2013-07-17
RU2010109750A (ru) 2011-09-27
US9248156B2 (en) 2016-02-02
BRPI0815188A2 (pt) 2015-03-31
US20160193272A1 (en) 2016-07-07
CN102065875A (zh) 2011-05-18
PL2182966T3 (pl) 2013-01-31
US20130251826A1 (en) 2013-09-26
ES2392310T3 (es) 2012-12-07
US8404286B2 (en) 2013-03-26
JP2010536718A (ja) 2010-12-02
EP2182966A1 (de) 2010-05-12

Similar Documents

Publication Publication Date Title
US20160193272A1 (en) Use of Extracts or Materials Extracted From Piper Cubeba L. as an Effective Component in a Drug for the Treatment of Cancer Diseases
EP2538933B1 (fr) L'huile essentielle d'origan pour le traitement des keratoses cancéreuses
JP6347611B2 (ja) メイラード反応抑制機能または抗酸化機能を有する機能剤
Mert et al. Essential oil and fatty acid composition and antioxidant capacity and total phenolic content of parsley seeds (Petroselinum crispum) grown in Hatay region
JP2006176436A (ja) Ｓｃｆ発現阻害剤
KR102057091B1 (ko) Nrf2 인덕션 리바이탈라이징 제제용 피이지프리 가용화제, 이를 포함하는 Nrf2 인덕션 리바이탈라이징 제제, 이를 포함하는 화장품 및 이의 제조방법
WO2006008917A1 (ja) デオドラント剤、デオドラント製剤、および繊維デオドラント処理方法
Yaseen et al. Formulation, characterization and in-vitro sun protection factor of a lemongrass sunscreen lotion: sun protection factor of a lemongrass sunscreen lotion
Parwanto et al. Effect of extreme temperature storage on flavonoids levels and antibacterial activity of Lantana camara Linn. leaf extract cream
EP2538932B1 (fr) Utilisation d'huile essentielle d'origan ou de bois de rose dans le traitement des keratoses actiniques
Sripoo et al. Preparation of oregano, coffee and black cumin aqueous formulation and its anti inflammatory activity
Bramki et al. Potential Use of Vitex agnus‐castus Hydroalcoholic Extract for Cosmetic Applications: In Vitro, In Silico, and Formulation Investigations
KR102003717B1 (ko) 땀 악취증 증상 개선효과를 가지는 조성물
Fakkham et al. Study of the Antioxidant Activity and Total Phenolic Content of Crude Extract from Michelia alba Flower
Khadea et al. Profiling volatile compounds from crude rhizome extract of Zingiber Zerumbet (L.) Smith by solid phase micro extraction and liquid chromatographyhigh resolution time of flight mass spectrometry
Istikhomah et al. Antioxidant Lotion Formulation with a Combination of Ethanol Extracts of Black Soybean and Pigeon Pea
JP4261413B2 (ja) メラニン産生抑制剤
JP2021107349A (ja) モッコウバラの抽出物を含有する皮膚外用剤
JP2023037173A (ja) テストステロン５α－レダクターゼ活性阻害剤及び抗男性ホルモン剤
CH698610B1 (de) Verwendung von Extrakten oder Extraktivstoffen aus Piper cubeba L. als wirksame Bestandteile in einem Medikament zur Behandlung von Krebserkrankungen.
Djalil et al. Formulation and Characterization of Sunscreen Lotion from Corn Cob (Zea mays L.) Extract
KR20190116817A (ko) 침향추출물을 포함하는 피부 미백용 화장료 조성물
KR20160118550A (ko) 초석잠 추출물을 유효성분으로 함유하는 광조사에 의한 피부 세포손상 예방 또는 치료용 약학조성물

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20150817